<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(11 0 0 11 304.712 779.9031) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.593 1.113 1.295 1.8 2.307 2.812 3.329 3.83 4.18 4.685 5.207 5.557 6.079 6.601 6.897 7.419 7.757 8.454 8.976 9.314 9.52 10.006 10.356 10.878 11.4 11.75 12.272 12.442 12.792 13.314 13.496 14.018 14.535 14.885 15.397 15.747 16.269 16.439 16.789 17.296 17.801 18.36 18.53 19.052 19.553 19.987 20.509 21.031 21.345" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">Cuidados de enfermería en el niño y el adolescente</svg:tspan></svg:text><svg:text transform="matrix(7.5 0 0 7.5 537.153 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.496 1.052" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">193</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.8949 1.2839 1.5059 1.7278 2.1168 2.3388 2.7828" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Asﬁ xia.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 745.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 745.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.561 1.783 2.172 2.394 2.672 2.894 3.338 3.782 4.004 4.448 4.67 5.114 5.503 5.947 6.336 6.78 7.058 7.502 7.78 8.058 8.502 8.891 9.169 9.613 9.891 10.335 10.557 11.001 11.445 11.834 12.278 12.5 12.944 13.222 13.666 14.11 14.554 14.998 15.442 15.831 16.275" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Déﬁ cit de glucosa-6-fosfato deshidrogenasa.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 734.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 734.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.802 1.246 1.524 1.746 2.19 2.634 2.912 3.356 3.745 3.967 4.411 4.855 5.299 5.521 5.91 6.354 6.743 6.965 7.409 7.853 8.297 8.519 8.963 9.241 9.685 10.074 10.352 10.796 11.24 11.462 11.684 12.128 12.35 12.794 13.183 13.461 13.683 14.072 14.294 14.738 15.182 15.626 15.848 16.292 16.514 16.958 17.347 17.791 18.069 18.513 18.957 19.179 19.401 19.679 19.957 20.401 20.845 21.234 21.512 21.956 22.234 22.678 23.067 23.511" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Variantes génicas que afectan la actividad glucuroniltransferasa.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 712.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 1 1.5 2 2.278 2.778 3 3.5 4 4.5 4.778 5 5.5 5.722 6.222 6.444 6.666 6.888 7.221 7.554 8.054 8.554 8.776 9.276 9.498 9.998 10.498 10.72 11.164 11.386 11.83 12.33 12.663 13.163 13.385 13.885 14.163 14.663 14.996 15.496" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)">Encefalopatía bilirrubínica y kernicterus</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 690.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 690.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3388 0.7828 1.2268 1.6158 2.0598 2.3378 2.7818 3.0038 3.4478 3.8918 4.3358 4.6138 4.8358 5.2798 5.5286 5.9726 6.1946 6.4166 6.6386 6.9166 7.1946 7.6386 8.0826 8.3046 8.7486 8.9706 9.3596 9.8036 10.0256 10.2744 10.7184 10.9404 11.3294 11.7734 11.9954 12.4394 12.8284 13.0772 13.5212 13.7432 14.1872 14.5762 15.0202 15.4642 15.9082 16.2972 16.546 16.99 17.434 17.6828 18.1268 18.3488 18.5708 18.7928 19.0708 19.3488 19.7928 20.2368 20.4588 20.9028 21.3468 21.5956 22.0396 22.4836 22.7324 23.1214 23.5654 24.0094 24.4534 24.7314 25.1754 25.4242 25.8682 26.3122 26.561 27.005 27.227 27.4758 27.7538 28.1978 28.5868 28.8088 29.2528 29.6968 29.9456 30.3896 30.8336 31.2226 31.4446 31.8886 32.3326 32.5814 33.0254 33.4694 33.9134 34.3574 34.8014 35.2454 35.4942 35.8832 36.3272 36.6052 36.854 37.132 37.576 37.965 38.187 38.576 39.02 39.409 39.6578 40.1018 40.5458 40.8238 41.2678 41.5166 41.9606 42.1826 42.4314 42.8204 43.2644 43.5424 43.9864 44.4304 44.7084 45.1524" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Encefalopatía bilirrubínica: niveles elevados de bilirrubina en sangre en el recién nacido pueden ser tóxicos para el cerebro.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 484.67701 690.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.2488 0.8048 1.2488 1.6928 1.9708 2.4148 3.0818 3.3038 3.6928 4.1368" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Anatómica-</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.370114 679.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.667 1.111 1.555 1.833 2.277 2.499 2.888 3.332 3.554 4.221 4.665 5.109 5.331 5.553 5.775 6.219 6.608 6.886 7.33 7.774 7.996 8.44 8.884 9.162 9.384 9.828 10.272 10.716 10.938 11.16 11.827 12.271 12.549 12.993 13.437 13.881 14.325 14.714 14.936 15.38 15.824 16.046 16.49 16.934 17.156 17.6 17.822 18.044 18.266 18.544 18.822 19.266 19.71 19.932 20.376 20.82 21.042 21.486 21.93 22.152 22.374 22.818 23.207 23.429 23.873 24.317 24.706 24.928 25.372 25.816 26.205 26.427 26.871 27.315 27.537 27.759 28.203 28.425 28.869 29.313 29.702 30.146 30.368 30.59 30.979 31.423 31.701 32.145 32.367 32.756 33.034 33.478 33.756 34.2 34.589 34.811" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">mente se maniﬁ estan por una impregnación de bilirrubina en los núcleos de la base (kernicterus).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 668.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 668.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.727 1.949 2.338 2.56 2.838 3.116 3.56 3.949 4.171 4.615 5.059 5.281 5.725 6.169 6.391 7.058 7.502 7.835 8.279 8.501 8.723 9.167 9.611 9.833 10.277 10.499 10.721 10.943 11.221 11.499 11.943 12.387 12.609 13.053 13.497 13.719 14.163 14.607 14.829 15.218 15.662 16.106 16.55 16.828 17.272 17.494 17.883 18.327 18.549 18.993 19.215 19.659 20.103 20.381 20.825 21.269 21.491 21.713 22.157 22.379 22.823 23.267 23.656 23.878 24.322 24.544 24.766 24.988 25.432 25.876 26.32 26.542 26.986 27.43 27.652 27.93 28.374 28.818 29.04 29.262 29.595 30.039 30.317 30.539 30.983 31.427 31.871 32.093 32.537 32.926 33.37 33.814 34.258 34.702 34.924 35.368 35.812 36.09 36.368 36.812 37.256 37.645 37.923 38.367 38.756 38.978 39.422 39.866 40.088" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Con cifras de 20 mg/dl de bilirrubina en sangre se plantea la posibilidad de realizar una exanguinotransfusión. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 646.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.42 0.753 1.253 1.531 2.031 2.753 2.975 3.475 3.975 4.253 4.753 4.975 5.475 5.975 6.197 6.419 6.919 7.141 7.641 7.863 8.363 8.863 9.196 9.696 9.918 10.14 10.362 10.695 11.028 11.528 12.028 12.25 12.75 13.25 13.972 14.194 14.694 14.916 15.416 15.916 16.416 16.916 17.416 17.694 18.194" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)">Tratamiento de la hiperbilirrubinemia neonatal</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 624.8375) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 624.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 1.172 1.45 1.894 2.172 2.616 2.894 3.338 3.782 4.004 4.448 4.67 5.114 5.336 5.614 5.892 6.336 6.614 7.058 7.725 7.947 8.391 8.835 9.113 9.557 9.779 10.168 10.612 11.056 11.278 11.5 11.944 12.277 12.499 12.721 12.999 13.277 13.721 13.999 14.443 15.11 15.332 15.776 16.22 16.498 16.942 17.164 17.608 18.052 18.274 18.718 18.94 19.384 19.773 20.162 20.384 20.828 21.272 21.494 21.938 22.382 22.604 22.826 23.27 23.492 23.714 24.103 24.381 24.825 25.103 25.325 25.714 25.936 26.38 26.602 27.046 27.49 27.768 27.99 28.434 28.656 29.1 29.544 29.822 30.266 30.488 30.71 30.932 31.21 31.488 31.932 32.376 32.598 33.042 33.486 34.153 34.375 34.819 35.041 35.485 35.929 36.151 36.54 36.984 37.428 37.65 38.094 38.538 38.982 39.426 39.87" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Fototerapia o tratamiento con luz: tratamiento de elección en la ictericia por hiperbilirrubinemia no conjugada.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.7829 1.1719 1.6159 2.0599 2.5039 2.9479 3.1699 3.6139 4.0579 4.3359 4.6139 5.0579 5.5019 5.8909 6.1689 6.6129 7.0019 7.2239 7.6679 8.1119" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Exanguinotransfusión.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 591.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.426 0.759 1.259 1.703 1.981 2.481 2.814 3.314 3.814 4.258 4.48 4.98 5.48 6.202 6.702 6.98 7.48 7.758 8.258 8.758 9.036 9.536 10.036" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Trastornos hematológicos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 569.8015) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 1 1.278 1.778 2.111 2.833 3.333 3.833 4.333 4.833 5.055 5.555 6.055 6.777 7.277 7.499 7.721 7.999 8.221 8.721 9.221 9.443 9.943 10.443 10.665 10.887 11.22 11.72 12.22 12.442 12.942 13.442 13.664 14.164 14.664 15.164 15.386 15.886" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)">Enfermedad hemolítica del recién nacido</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 547.837) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 547.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.672 2.116 2.338 2.616 3.06 3.504 3.948 4.17 4.614 5.058 5.28 5.502 5.946 6.168 6.39 6.834 7.223 7.667 8.334 8.778 9.222 9.5 9.722 10.166 10.388 10.61 10.832 11.276 11.72 12.164 12.386 12.775 13.219 13.663 14.107 14.551 14.773 15.217 15.661 16.105 16.327 16.771 17.215 17.437 17.659 17.937 18.381 18.77 19.048 19.492 19.77 19.992 20.492 20.936 21.158 21.602 21.824 22.268 22.712 22.934 23.156 23.6 23.878 24.322 24.766 25.21 25.432 25.988 26.488 26.932 27.154 27.376 27.82 28.264 28.542 28.82 29.264 29.486 29.708 30.152 30.374 31.041 31.485 31.929 32.207 32.651 32.873 33.262 33.484 33.873 34.317 34.539 34.983 35.205 35.427 35.871 36.093" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Resultado de la incompatibilidad sanguínea del factor Rh o del grupo AB0, entre la madre y su hijo. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 536.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 536.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 1.172 1.394 2.061 2.505 2.894 3.116 3.56 3.838 4.282 4.671 5.115 5.337 5.726 5.948 6.337 6.781 7.225 7.447 8.114 8.558 8.947 9.391 9.669 9.891 10.169 10.447 10.891 11.28 11.669 12.113 12.557 13.001 13.445 13.889 14.278 14.5 14.944 15.166 15.555 15.777 15.999 16.443 16.665 17.054 17.498 17.72 18.164 18.553 18.775 18.997 19.441 19.663 19.885 20.274 20.718 20.94 21.384 22.051 22.495 22.939 23.161 23.494 23.938 24.327 24.549 24.993 25.437 25.659 26.159 26.603" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> La más grave y con mayor trascendencia clínica es la isoinmunización Rh.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 525.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 525.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.561 0.95 1.394 1.616 2.06 2.727 3.171 3.615 3.837 4.17 4.614 5.003 5.225 5.669 6.113 6.335 6.835 7.279 7.501 7.723 8.167 8.611 8.889 9.111 9.389 9.945 10.167" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Isoinmunización Rh (anti-D):</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 514.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.333 2.777 3.221 3.665 3.887 4.331 4.775 5.219 5.441 6.108 6.552 6.774 7.218 7.496 7.718 8.218 8.662 8.94 9.162 9.606 10.05 10.272 10.661 11.105 11.327 11.771 12.049 12.271 12.938 13.382 13.66 13.882 14.326 14.993 15.437 15.881 16.159 16.603 16.936 17.38 17.602 17.88 18.102 18.546 18.99 19.434 19.656 20.1 20.544 20.766 21.21 21.432 21.654 22.098 22.32 22.82 23.264 23.708 23.93 24.152 24.596 25.04 25.484 25.928 26.372 26.594 27.038 27.316 27.76 28.204 28.648 29.037 29.259 29.537 29.926 30.37 30.592 31.036 31.258 31.48 31.924 32.368 32.757 33.201 33.423 33.867 34.311 34.533 34.922 35.366 35.81 36.254 36.532 36.976 37.198 37.476 37.92 38.198 38.642 38.864 39.086 39.53 39.752 39.974 40.418 40.64 41.029 41.251 41.529 41.918 42.362 42.584 43.028 43.417 43.639 44.083 44.527 44.749 45.416 45.86 46.138 46.582" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Cuando una mujer Rh- en su primer embarazo tiene un hijo Rh+, puede producirse el paso de sangre fetal a la circulación mater</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 501.094793 514.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.11" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">na. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 503.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.667 1.889 2.333 2.722 3 3.444 3.666 4.11 4.499 4.943 5.221 5.499 5.943 6.165 6.387 6.831 7.053 7.275 7.664 7.886 8.275 8.553 8.997 9.664 10.108 10.33 10.552 10.996 11.663 12.107 12.551 12.995 13.217 13.661 14.105 14.327 14.716 15.16 15.382 15.826 16.27 16.492 16.714 17.158 17.38 18.047 18.491 18.935 19.213 19.657 19.879 20.323 20.767 21.156 21.6 21.878 22.156 22.6 22.822 23.044 23.488 23.71 24.154 24.598 24.876 25.098 25.487 25.931 26.375 26.653 27.097 27.541 27.93 28.152 28.541 28.985 29.429 29.707 29.985 30.429 30.651 31.095 31.484 31.762 32.206 32.428 32.706 33.15 33.539 33.817 34.261 34.539 34.761 35.261 35.705 36.149" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Si esto ocurre, el sistema inmunológico de la madre desarrolla anticuerpos contra este factor Rh+.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 492.838599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.778 2.056 2.5 2.722 3.166 3.444 3.666 4.333 4.777 5.055 5.277 5.555 5.999 6.388 6.61 7.054 7.498 7.72 8.164 8.608 8.997 9.219 9.663 10.107 10.329 10.773 11.217 11.439 11.883 12.161 12.605 12.994 13.438 13.882 14.16 14.604 14.882 15.326 15.548 15.992 16.214 16.658 17.102 17.546 17.99 18.212 18.656 18.934 19.378 19.822 20.044 20.488 21.155 21.599 21.821 22.21 22.432 22.654 22.876 23.32 23.542 24.209 24.653 25.097 25.375 25.819 26.041 26.43 26.874 27.096 27.54 27.984 28.206 28.595 29.039 29.483 29.872 30.094 30.538 30.76 30.982 31.204 31.537 31.981 32.425 32.869 33.091 33.535 33.757 33.979 34.201 34.423 34.867 35.311 35.533 35.755 36.199 36.643 36.865 37.087 37.531 38.198 38.642 39.086 39.364 39.808 40.141 40.585" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Este primer recién nacido no presentará ningún problema si la madre se ha sensibilizado al ﬁ nal del embarazo.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 481.838799) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.667 1.889 2.111 2.555 2.777 3.166 3.61 4.054 4.443 4.665 5.109 5.331 5.553 5.775 6.108 6.552 6.941 7.163 7.607 8.051 8.273 8.717 9.161 9.383 9.661 10.105 10.549 10.771 11.215 11.659 11.881 12.103 12.547 12.991 13.435 13.713 13.935 14.379 14.823 15.045 15.489 15.933 16.377 16.655 16.933 17.377 17.766 17.988 18.432 18.654 19.098 19.765 20.209 20.653 20.931 21.375 21.708 22.152 22.541 22.763 23.207 23.651 23.929 24.373 24.651 24.873 25.317 25.595 26.039 26.428 26.65 26.872 27.316 27.76 28.204 28.648 29.092 29.314 29.758 30.202 30.646 30.868 31.312 31.701 31.979 32.423 32.812 33.034 33.478 33.922 34.2 34.422 34.811 35.255 35.699 35.977 36.421 36.865 37.254 37.476 37.865 38.087 38.309 38.753 39.031 39.475 39.864 40.142 40.586 41.03 41.252 41.696 41.918 42.14 42.418 42.862 43.251 43.473 43.917 44.361 44.583 45.027 45.471" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Si la sensibilización ha tenido lugar en abortos o embarazos anteriores, puede que estos anticuerpos sí afecten al recién nac</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 492.094793 481.838799) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">ido.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 470.838999) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2 2.389 2.833 3.277 3.666 4.11 4.499 4.943 5.387 5.831 6.22 6.442 6.886 7.108 7.552 7.941 8.163 8.385 8.829 9.051 9.495 9.939 10.328 10.606 10.884 11.328 11.717 12.106 12.328 12.772 13.216 13.438 13.882 14.326 14.548 14.77 15.214 15.603 15.825 16.269 16.713 17.38 17.824 18.102 18.324 18.768 19.157 19.379 19.657 20.101 20.379 20.823 21.045 21.489 21.878 22.1 22.322 22.766 23.21 23.654 23.876 24.32 24.764 24.986 25.208 25.652 26.096 26.54 26.818 27.04 27.484 27.706 28.15 28.594 29.038 29.26 29.704 30.148 30.592 31.259 31.481 31.925 32.147 32.591 33.035 33.702 34.146 34.368 34.59 34.868 35.09 35.479 35.923 36.145 36.423 36.867 37.145 37.589 37.811 38.033 38.422 38.644 39.088 39.532 39.976 40.42 40.864 41.142 41.586 41.808" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- La consecuencia es la destrucción de los hematíes fetales, que da lugar a una anemia hemolítica fetal y neonatal.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 459.839199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9448 1.3338 1.7778 2.0066 2.2286 2.6726 3.0616 3.2836 3.7276 4.1716 4.6156 5.0046 5.2266 5.6706 5.8994 6.3434 6.7874 7.0162 7.4602 7.6822 8.0712 8.7382 8.9602 9.4042 9.8482 10.0702 10.5142 10.9582 11.187 11.854 12.298 12.687 13.131 13.575 13.8038 14.2478 14.6918 15.0808 15.5248 15.9688 16.1976 16.6416 17.0856 17.5296 17.7584 18.1474 18.5914 18.8202 19.2642 19.7082 20.3752 20.5972 21.0412 21.2632 21.6522 21.9302 22.2082 22.6522 22.881 23.325 23.5538 23.7758 24.2198 24.6088 24.8376 25.5046 25.9486 26.3926 26.6706 27.1146 27.5036 27.7324 28.2324 28.6764 28.9544 29.1832 29.4052 29.8492 30.5162 30.9602 31.4042 31.8482 32.2922 32.5142 32.9582 33.4022 33.8462 34.0682 34.2902 34.7342 35.1782 35.407 35.851 36.295 36.573 36.795 37.073 37.629 37.8578 38.3018 38.7458 38.9746 39.4186 39.8626 40.0914 40.5354 40.7574 41.2014 41.5344 41.9784 42.2072 42.6512 43.0952 43.324 43.768 44.212 44.4408 44.8848 45.1136 45.5576 46.0016 46.3906 46.8346 47.2786 47.7226" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- La incidencia ha disminuido mucho desde que se administra a las madres Rh- inmunoglobulina anti-D en un plazo de 72 h después</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 512.360998 459.839199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.2288 0.6728 1.1168 1.3388" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> del </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 87.874205 448.839399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.166 1.444 1.888 2.11 2.3844 2.7734 3.2174 3.6614 4.1054 4.5494 4.9934 5.2678 5.7118 5.9338 6.2082 6.4862 6.9302 7.3192 7.5412 7.9852 8.4292 8.7036 9.1476 9.5916 9.9806 10.2026 10.6466 11.0906 11.365 11.809 12.198 12.4724 12.9724 13.4164 13.8604 14.0824 14.3568 14.7268 15.1708 15.8378 16.2818 16.5038 16.9478 17.3918 17.6662 18.1102 18.4992 18.7736 18.9956 19.6626 20.1066 20.5506 20.8286 21.1066 21.5506 21.9946 22.2726 22.7166 22.991 23.435 23.879 24.546 24.768 25.212 25.434 25.823 26.101 26.379 26.823 27.101 27.323 27.767 28.0414 28.3194 28.5974 29.0414 29.4304 29.7048 30.3718 30.8158 31.2598 31.4818 31.9258 32.3698 32.6478 33.0918 33.4808 33.7552 34.1992 34.6432 35.0872 35.3616 35.8056 36.2496 36.6936 37.1376 37.5816 38.0256 38.3 38.578 39.022 39.411 39.855 40.133 40.577 40.966 41.41 41.688 41.9624 42.4064 42.6284 42.9028 43.3468 43.7908 44.1798 44.6238 44.8982 45.3422 45.7862 46.0606 46.4496 46.8936 47.3376 47.7816" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">parto, cuando el recién nacido es Rh+. También es importante administrarla tras maniobras que pueden favorecer el paso de sangr</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 520.414217 448.839399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">e </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 87.874205 437.839598) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1 1.444 1.666 1.888 2.332 2.554 2.776 3.22 3.442 4.109 4.553 4.997 5.275 5.719 5.941 6.219 6.663 6.885 7.329 7.718 7.94 8.329 8.773 9.44 9.884 10.106 10.55 11.217 11.661 11.883 12.327 12.716 13.16 13.604 13.882 14.326 14.715 14.937 15.326 15.548 15.992 16.214 16.658 16.88 17.324 17.768 18.157 18.379 18.823 19.045 19.434 19.878 20.156 20.378 20.822 21.044" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">fetal a la madre tales como amniocentesis o biopsia corial.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 415.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 415.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.5609 0.9499 1.3939 1.6159 2.0599 2.7269 3.1709 3.6149 3.8369 4.1699 4.6139 5.0029 5.2249 5.6689 6.1129 6.3348 6.8908 7.3908 7.8348" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Isoinmunización AB0:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 404.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.333 2.722 3.166 3.388 4.055 4.499 4.888 5.11 5.499 5.943 6.61 7.054 7.498 7.72 8.164 8.608 8.83 9.052 9.441 9.885 10.107 10.551 11.218 11.662 12.106 12.328 12.661 13.105 13.494 13.716 14.16 14.604 14.826 15.27 15.714 15.936 16.158 16.602 16.824 17.268 17.657 17.935 18.379 18.823 19.045 19.267 19.711 20.155 20.599" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Causa más común de isoinmunización en la actualidad.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 393.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2 2.222 2.611 3.055 3.277 3.721 4.388 4.832 5.276 5.498 5.831 6.275 6.664 6.886 7.33 7.774 7.996 8.385 8.829 9.051 9.495 9.773 10.217 10.661 11.105 11.494 11.938 12.16 12.549 12.993 13.437 13.881 14.325 14.769 14.991 15.213 15.657 15.879 16.268 16.712 17.156 17.6 17.878 18.322 18.544 18.822 19.266 19.544 19.988 20.21 20.432 20.821 21.265 21.709 21.987 22.209 22.653 23.097 23.541 23.763 24.207 24.651 24.873 25.317 25.761 26.039 26.261 26.705 27.149 27.593 28.037 28.259 28.815 29.037 29.481 29.703 30.203 30.425 30.869 31.313 31.757 31.979 32.201 32.645 32.867 33.534 33.978 34.422 34.7 35.144 35.366 35.81 36.254 36.476 36.92 37.364 37.753 38.197 38.641" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- La isoinmunización se produce cuando la sangre fetal contiene un antígeno A o B que la madre no posee.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 382.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.611 1.833 2.5 2.944 3.333 3.777 4.221 4.443 4.832 5.499 5.943 6.165 6.609 6.998 7.22 7.664 7.886 8.108 8.775 8.997 9.386 10.053 10.497 10.719 11.163 11.607 12.051 12.273 12.717 13.161 13.383 13.605 14.049 14.271 14.493 14.882 15.326 15.548 15.992 16.659 17.103 17.547 17.769 18.102 18.546 18.935 19.157 19.601 20.045 20.267 20.711 21.155 21.433 21.655 21.933 22.489 22.711" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- El mecanismo es el mismo que en la isoinmunización anti-D. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 371.8388) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2 2.444 2.722 3.166 3.555 3.999 4.443 4.887 5.331 5.553 5.997 6.441 6.663 6.885 7.329 7.551 7.773 8.162 8.606 8.828 9.272 9.939 10.383 10.827 11.049 11.382 11.826 12.215 12.437 12.881 13.325 13.547 14.103 14.603 15.047 15.269 15.713 16.157 16.379 16.823 17.267 17.934 18.378 18.822 19.1 19.544 19.766 20.21 20.654 20.876 21.32 21.987 22.431 22.875 23.153 23.597 23.93 24.374 24.763 24.985 25.374 25.818 26.207 26.651 27.04 27.262 27.651 28.095 28.484" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- La gravedad de la isoinmunización AB0 no aumenta en embarazos sucesivos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 349.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 2.333 2.555 3.055 3.277 3.777 4.277 4.499 4.721 5.221 5.443 5.943 6.276 6.776 7.498 7.998 8.276 8.776 9.109 9.331 9.831 10.331" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)">Anemia de la prematuridad</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 327.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 327.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.783 2.45 2.672 3.116 3.338 4.005 4.227 4.616 4.894 5.338 5.727 5.949 6.227 6.449 6.838 7.282 7.504 7.948 8.17 8.614 8.836 9.28 9.724 10.002 10.28 10.724 11.168 11.612 12.056 12.5 12.778 13.222 13.5 13.722 14.111 14.555" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Anemia microcítica e hiporregenerativa.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.505 2.172 2.616 3.06 3.282 3.504 3.726 4.17 4.559 4.837 5.281 5.503 5.947 6.169 6.613 7.057 7.335 7.613 7.835 8.113 8.335 8.779 9.223 9.445 9.667 10.111 10.333 10.722 11.166 11.61 12.054 12.498 12.942 13.386 13.608 14.052 14.274 14.496 14.94 15.162 15.44 15.884 16.162 16.551 16.995 17.273 17.717 17.939 18.328 18.772 19.439 19.883 20.327 20.771 20.993 21.437 21.881 22.103 22.492 22.714 23.158 23.602" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Se maniﬁ esta a partir de la segunda o la tercera semana de vida.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 305.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 305.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.561 1.783 2.172 2.394 2.672 2.894 3.283 3.505 3.783 4.227 4.449 4.727 5.171 5.393 5.837 6.281 6.503 6.781 7.225 7.614 8.058 8.502 8.946 9.335 9.613 10.057 10.279 10.723 10.945 11.167 11.611 11.833 12.277 12.555 12.777 13.055 13.333 13.777 14.221 14.665 15.054 15.498 15.776 15.998 16.442 16.886" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Déﬁ cit y falta de respuesta a la eritropoyetina.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 294.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 294.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.709 0.987 1.431 1.709 2.153 2.82 3.042 3.486 3.93 4.208 4.652 4.874 5.096 5.54 5.818 6.04 6.318 6.596 7.04 7.484 7.928 8.317 8.761 9.039 9.261 9.705 10.149 10.371 10.649 11.093 11.482 11.926 12.593 13.037 13.259 13.703 14.147 14.591 14.869 15.313 15.535 15.979 16.423 17.09 17.534 17.978 18.422 18.644 19.088 19.532 19.81 20.032 20.421 20.643 21.087 21.309 21.698 22.142 22.586 22.975 23.419 23.697 24.141 24.585 25.029 25.473 25.695 26.084 26.306 26.695 27.139 27.806 28.25 28.472 28.916 29.583 30.027 30.471 30.749 31.193 31.582 31.804 32.248 32.692 32.914 33.358 33.58 34.024 34.302 34.58 35.024 35.246 35.635 35.857 36.301 36.579 37.023 37.301 37.745 37.967 38.411 38.855 39.244" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Tratamiento: eritropoyetina recombinante humana por vía subcutánea y complementos de hierro y proteínas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 272.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 1 1.278 1.778 2.111 2.833 3.333 3.833 4.333 4.833 5.055 5.555 6.055 6.777 7.277 7.61 7.943 8.443 8.943 9.165 9.665 10.165 10.387 10.887 11.387 11.609 11.831 12.164 12.664 13.164 13.386 13.886 14.386 14.608 15.108 15.608 16.108 16.33 16.83" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)">Enfermedad hemorrágica del recién nacido</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 250.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.166 1.61 1.888 2.555 2.999 3.443 3.887 4.331 4.553 4.997 5.441 6.108 6.552 6.83 7.108 7.552 7.996 8.218 8.607 9.051 9.273 9.717 10.161 10.439 10.661 11.105 11.549 11.771 11.993 12.382 12.604 12.882 13.104 13.548 13.992 14.214 14.603 14.825 15.103 15.547 16.214 16.436 16.88 17.324 17.546 18.046 18.268 18.49 18.768 19.046 19.49 19.879 20.157 20.601 20.879 21.323 21.767 21.989 22.433 22.877 23.544 23.988 24.266 24.544 24.988 25.432 25.654 26.043 26.487 26.709 27.376 27.82 28.209 28.431 28.82 29.264 29.542 29.986 30.375 30.653 31.097 31.375 31.597 31.986 32.264 32.486 32.875 33.319" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Enfermedad hemorrágica por déﬁ cit de vitamina K: trastorno hemorrágico más característico.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 228.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 228.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.7829 1.1719 1.6159 2.0599 2.4489 2.6709 3.1149 3.3369 3.5588 3.8368 4.0588 4.5028 4.8918 5.3358 5.7798 6.0018" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Especial riesgo: </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 217.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.3889 1.6669 2.1109 2.7779 3.2219 3.4999 3.9439 4.2219 4.6659 5.0549" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Prematuros.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 206.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.723 1.945 2.389 2.778 3 3.444 3.888 4.11 4.777 5.221 5.665 5.943 6.387 6.776 6.998 7.442 7.886 8.108 8.33 8.774 9.218 9.496 9.718 10.107 10.551 10.94 11.162 11.606 12.05 12.494 12.716 12.994 13.438 14.105 14.549 14.993 15.215 15.882 16.326 16.77 16.992 17.381 17.825 18.214 18.436 18.88 19.324 19.546 19.99 20.434 20.712 20.934 21.323 21.767 22.211 22.6 23.044 23.266 23.655 23.877 24.266 24.71 24.932 25.376 25.82 26.098 26.542 26.986 27.264 27.708 27.93 28.374 28.596 28.818 29.262 29.929 30.373 30.817 31.095 31.539 31.872 32.316" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Hijos de madres epilépticas que toman medicación anticonvulsiva durante el embarazo.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 195.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.556 1.778 2.222 2.666 3.055 3.277 3.666 4.11 4.554 4.776 4.998 5.442 5.831 6.109 6.553 6.997 7.386 7.608 8.052 8.274 8.941 9.385 9.663 10.107 10.385 10.829 11.273" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Niños con lactancia materna.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 184.8388) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.945 2.389 2.833 3.055 3.277 3.721 4.11 4.332 4.776 5.22 5.664 5.886 6.33 6.774 6.996 7.274 7.718 8.107 8.329 8.773 9.217 9.661 9.883 10.272 10.494 10.772 11.216 11.883 12.105 12.549 12.993 13.215 13.715 13.937 14.381 14.825 15.103 15.325 15.714 15.936 16.38 16.602 16.824 17.268 17.546 17.824 18.268 18.935 19.379 19.768 20.157 20.601 20.823 21.267 21.475 21.697 21.919 22.363 22.585 23.029 23.473 23.862 24.084 24.473 24.695 25.139 25.583 25.805 26.249 26.471 27.138 27.582 27.804 28.026 28.47 28.692 28.914 29.358 29.802 30.191 30.413 31.08 31.302 31.746 32.19 32.468 32.912 33.134" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Aquellos que no reciben vitamina K por vía intramuscular, a dosis de 1 mg, al nacimiento. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 162.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 162.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.505 1.949 2.227 2.671 3.115 3.559 3.948 4.392 4.614 5.058 5.28 5.558 6.002 6.446 6.89 7.334 7.778 8.056 8.278 8.722 9.166 9.388 9.61 9.888 10.332 10.61 10.999 11.443 11.721 11.943 12.387 12.609 13.053 13.275 13.719 14.163 14.385 14.774 14.996 15.44 15.884" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Se produce alrededor del tercer día de vida.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.727 1.949 2.393 2.837 3.059 3.503 3.781 4.225 4.669 5.113 5.78 6.002 6.446 6.89 7.168 7.39 7.612 8.056 8.445 8.667 9.111 9.555 10.222 10.666 10.944 11.222 11.666 12.11 12.332 12.776 13.165 13.387 13.831 14.053 14.497 14.941 15.33 15.608 15.83 16.219 16.663 17.052" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Suelen predominar las hemorragias digestivas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 129.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 1.056 1.278 1.5 2 2.222 2.722 3.222 3.722 3.944 4.166 4.666 4.888 5.388 5.888 6.388 6.888 7.388 7.666 8.166 8.388 8.61 8.888 9.332 9.554 10.054 10.554 10.887 11.387 12.109 12.609 12.831 13.331 13.831 14.053 14.553 14.775 15.275 15.775 16.108 16.552 16.774 17.218 17.718 18.218 18.662 18.884 19.384 19.884 20.384 20.606 21.05 21.55 22.05 22.55 23.05 23.272 23.772 24.272 24.772" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)">Poliglobulia neonatal (síndrome de hiperviscosidad sanguínea)</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 107.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 107.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 2.006 2.45 2.728 3.172 3.561 3.839 4.061 4.339 4.783 5.005 5.394 5.838 6.282 6.726 7.004 7.226 7.67 7.948 8.17 8.614 8.836 9.058 9.502 9.946 10.724" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Hematocrito superior al 65%.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 96.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 96.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 2.006 2.45 2.894 3.116 3.56 4.004 4.226 4.67 5.114 5.336 5.725 6.169 6.613 7.057 7.335 7.557 8.001 8.279 8.501 8.945 9.167 9.611 10.055 10.277 10.721 11.054 11.498 11.72 11.942" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Hemoglobina superior a 22 g/dl. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.117 1.561 2.005 2.283 2.672 2.894 3.283 3.672 4.116 4.505 4.727 5.171 5.615 6.059 6.281 6.725 7.169 7.391 7.613 8.057 8.279 8.668 9.112 9.556 10 10.278 10.722 10.944 11.166 11.61 11.832 12.221 12.888 13.11 13.554 13.998 14.387 14.609 15.053 15.497 15.719 16.163 16.607 16.829 17.273 17.717 18.161 18.439 18.717 19.161 19.383 19.827 20.271 20.493 20.937 21.326 21.548 21.992 22.436 22.88 23.324 23.546 23.99 24.212 24.434 24.878 25.267 25.489 25.878 26.322 26.544 26.988 27.21 27.654 28.043" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Hiperviscosidad de la sangre: disminución de aporte de oxígeno a las células.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.727 2.116 2.56 2.949 3.171 3.615 4.059 4.281 4.725 5.169 5.391 5.613 6.057 6.279 6.723 7.167 7.611 7.833 8.055 8.499" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Causas de poliglobulia:</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>